Too short stature, too many stigmata

Area of Science:

• Hematology
• Pediatrics
• Genetics

Background:

• Dyskeratosis congenita (DC) is a rare inherited bone marrow failure syndrome.
• DC is characterized by a triad of reticulate skin pigmentation, oral leukoplakia, and nail dystrophy.
• Patients often present with progressive bone marrow failure, increasing the risk of myelodysplastic syndromes and acute myeloid leukemia.

Observation:

• Short stature is a common feature in children with DC.
• Growth hormone (GH) deficiency is not the typical cause of short stature in DC.
• This case highlights a 10-year-old boy diagnosed with both DC and GH deficiency.

Findings:

• The patient presented with clinical features consistent with Dyskeratosis congenita.
• Growth hormone deficiency was identified as a co-occurring condition.
• The interplay between DC and GH deficiency requires careful consideration for treatment.

Implications:

• Growth hormone replacement therapy in DC patients warrants cautious administration.
• Potential risks of GH therapy, including predisposition to hematological malignancy, must be weighed.
• This case underscores the importance of individualized treatment strategies for children with rare genetic disorders like DC.